SE9303740D0 - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
SE9303740D0
SE9303740D0 SE9303740A SE9303740A SE9303740D0 SE 9303740 D0 SE9303740 D0 SE 9303740D0 SE 9303740 A SE9303740 A SE 9303740A SE 9303740 A SE9303740 A SE 9303740A SE 9303740 D0 SE9303740 D0 SE 9303740D0
Authority
SE
Sweden
Prior art keywords
pharmaceutical composition
abnormalities
mammal
calcium
salt
Prior art date
Application number
SE9303740A
Other languages
Swedish (sv)
Other versions
SE9303740L (en
Inventor
Shabtay Dikstein
Leena Lauren
Pertti Rantala
Kirsi Katila
Original Assignee
Leiras Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leiras Oy filed Critical Leiras Oy
Priority to SE9303740A priority Critical patent/SE9303740L/en
Publication of SE9303740D0 publication Critical patent/SE9303740D0/en
Priority to AU81083/94A priority patent/AU8108394A/en
Priority to PCT/FI1994/000504 priority patent/WO1995013078A1/en
Publication of SE9303740L publication Critical patent/SE9303740L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention concerns the use of clodronic acid or a salt thereof for making a pharmaceutical composition for the rectal treatment of abnormalities in the calcium and phosphate metabolism in a mammal.
SE9303740A 1993-11-12 1993-11-12 Pharmaceutical composition SE9303740L (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE9303740A SE9303740L (en) 1993-11-12 1993-11-12 Pharmaceutical composition
AU81083/94A AU8108394A (en) 1993-11-12 1994-11-09 Pharmaceutical composition and use thereof
PCT/FI1994/000504 WO1995013078A1 (en) 1993-11-12 1994-11-09 Pharmaceutical composition and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9303740A SE9303740L (en) 1993-11-12 1993-11-12 Pharmaceutical composition

Publications (2)

Publication Number Publication Date
SE9303740D0 true SE9303740D0 (en) 1993-11-12
SE9303740L SE9303740L (en) 1995-05-13

Family

ID=20391728

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9303740A SE9303740L (en) 1993-11-12 1993-11-12 Pharmaceutical composition

Country Status (3)

Country Link
AU (1) AU8108394A (en)
SE (1) SE9303740L (en)
WO (1) WO1995013078A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH9776A (en) * 1967-12-11 1976-03-17 M Francis Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue and method of use
NL175882C (en) * 1977-03-28 Procter & Gamble PHARMACEUTICAL PREPARATION CONTAINING AN ANTI-INFLAMMATORY COMPOUND.

Also Published As

Publication number Publication date
SE9303740L (en) 1995-05-13
WO1995013078A1 (en) 1995-05-18
AU8108394A (en) 1995-05-29

Similar Documents

Publication Publication Date Title
DK0891776T3 (en) Granular composition comprising simethicone and granular anhydrous calcium phosphate
EP0520690A3 (en) Calcium phosphate type hardening material for repairing living hard tissue
ZA943744B (en) Therapeutic substituted guanidines
IL108845A0 (en) Use of anticonvulsants in the treatment of neuro-aids
TW268937B (en)
FI972308A0 (en) 2-Substituted 1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions containing them and methods for their use
UA26973A1 (en) Agent for prophylaxis of the vascular diseases coused by the action of glycoproteinconnected peroxides
EP0449405A3 (en) Use of bisphosphonic acids for the treatment of calcium metabolism disorders
MXPA94009086A (en) Therapeutic substituted guanidines.
TR200000455T2 (en) The use of fanquinone in the treatment of Alzheimer's disease.
ES2078904T3 (en) NEW DERIVATIVES OF NEPLANOCINA.
BR9811643A (en) Chemical bone supplementation
SE9303740D0 (en) Pharmaceutical composition
AP9200355A0 (en) "Therapeutic agent"
IL111137A0 (en) Process for the electrochemical dissolution of sulfur-containing and/or concentrated minerals
MX9201825A (en) PHARMACEUTICAL COMPOSITION CONTAINING CALCITONIN.
FI945594A (en) Thio-substituted cyclic phosphonate compounds for the treatment of abnormal calcium and phosphate metabolism
NO972558L (en) Set for osteoporosis treatment cycle
FI961171A (en) Method for the treatment of acute myocardial infarction with hirudin and acetylsalicylic acid in patients not receiving thrombolytic therapy
FI945598A (en) Quaternary nitrogen-containing phosphonate compounds for the treatment of abnormal calcium and phosphate metabolism
GR77250B (en)
SI0828483T1 (en) Use of tropolone derivatives as inhibitors of the enzyme inositol monophosphatase
NO304011B1 (en) Use of atipamezole in the manufacture of a medicament for the treatment of men's impotence
GB9700697D0 (en) Combination of an androgen and a bisphosphonic acid in the prevention and/or treatment of diseases involving calcium or phosphate metabolism

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 9303740-6

Format of ref document f/p: F